Standard Shoe (523351)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Reported ROE of 18.26% hints at historical capital efficiency if the underlying equity base is real and profitable.
• Small market cap of ₹7 Cr means a modest absolute investment could transform the company's fortunes, offering optionality in a revival.
• No dividend payout means whatever limited resources exist are not being drained away as cash outflows.
• Being listed on NSE/BSE provides transparent price discovery and an exit route for investors.

Concerns

• Latest quarter sales and net profit are ₹0 crore; no current earnings power exists, making the P/E meaningless.
• Book value, debt/equity and promoter holding are all N/A, so balance-sheet risk and ownership alignment cannot be assessed.
• Piotroski F-Score of 2/9 indicates poor financial health and probable operational distress.
• Price of ₹12.89 is below the 52-week range low of ₹17.73, signalling ongoing de-rating and no visible floor.

AI Analysis

As a value investor, I first look for a business I can understand, then for numbers I can trust. Standard Shoe—listed under 'Specialty Chemicals'—fails both tests. It trades at ₹12.89 with a market cap of ₹7 crore. A P/E of 0.00 tells me there are no earnings. The latest quarter shows sales of ₹0 crore and net profit of ₹0 crore. So what is the ROE of 18.26% based on? I cannot reconcile it. ROCE is 0.00%, and book value is N/A. Graham would say this is not a stock; it is a piece of paper with missing pages. The Piotroski F-Score of 2/9 reinforces my suspicion: the financial health is poor. Growth rates of 0.00% are meaningless when the base itself is zero. There is no dividend yield, so I am not being paid to wait. The current price of ₹12.89 sits below the 52-week range of ₹17.73–₹22.52. That is not a bargain; it is a warning that the market has been marking this down and still cannot find a floor. With promoter holding N/A, I cannot even see whether the people running it have skin in the game. Buffett says, 'It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price.' This is neither. A ₹7 crore shell with zero sales, zero profits, and no disclosed balance sheet offers no margin of safety. I cannot value it, so I cannot buy it. A true bargain requires assets, earnings, or cash flows I can measure. Here, the only measurable 'strength' is the reported ROE, but with zero current profit I distrust it. I will watch for audited numbers and a genuine improvement in fundamentals. Until then, I pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer